French Pharmacovigilance Public System and COVID-19 Pandemic

The current COVID-19 pandemic is an exceptional health situation including for drug use. As there was no known effective drug for COVID-19 at the beginning of the pandemic, different candidates were proposed. In this short article, we present the French public pharmacovigilance activities during thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandvuillemin, Aurélie, Drici, Milou-Daniel, Jonville-Bera, Annie Pierre, Micallef, Joelle, Montastruc, Jean Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Current Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769328/
https://www.ncbi.nlm.nih.gov/pubmed/33372244
http://dx.doi.org/10.1007/s40264-020-01034-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769328/
https://www.ncbi.nlm.nih.gov/pubmed/33372244
http://dx.doi.org/10.1007/s40264-020-01034-y

Ejemplares similares